Answers are grounded in this paper and cite their sources.
This deposit contains a reproducible audit capsule for rewarded-action payout adjudication. The public surface combines a manuscript packet, a deterministic synthetic 10,150-event benchmark, a public verdict-envelope schema, a release-local validator, checksum manifests, and a receipt trail that binds the released bundle at publication level. The artifact demonstrates a narrow systems claim: externally claimed commercial actions can be exposed through a reviewable object containing a typed claim, evidence references, a machine-readable verdict, bundle-level receipt binding, and an appeal path. The public benchmark is a conformance and replay artifact, not partner traffic. App, campaign, partner, and device identifiers in the released rows are synthetic placeholders, and the release does not claim live fraud lift, production efficacy, or transfer from the synthetic benchmark to customer traffic.
No takes yet. Share an insight, caveat, or question.
Noah Erlwein (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: